These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10935255

  • 1. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T, Martínez-Yélamos A.
    Rev Neurol; ; 30(12):1223-7. PubMed ID: 10935255
    [Abstract] [Full Text] [Related]

  • 2. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 3. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 5. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.
    Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413
    [Abstract] [Full Text] [Related]

  • 6. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM.
    J Neurol; 2003 Feb 15; 250(2):171-8. PubMed ID: 12574947
    [Abstract] [Full Text] [Related]

  • 7. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Fisher E, Chang A, Fox RJ, Tkach JA, Svarovsky T, Nakamura K, Rudick RA, Trapp BD.
    Ann Neurol; 2007 Sep 15; 62(3):219-28. PubMed ID: 17427920
    [Abstract] [Full Text] [Related]

  • 8. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
    Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL.
    Semin Neurol; 1998 Sep 15; 18(3):327-36. PubMed ID: 9817537
    [Abstract] [Full Text] [Related]

  • 9. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb 15; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 10. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC, Hughes P, Perry VH.
    Rev Neurol; 2009 Feb 15; 30(12):1203-8. PubMed ID: 10935251
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M, Agosta F.
    Prog Brain Res; 2009 Feb 15; 175():465-82. PubMed ID: 19660674
    [Abstract] [Full Text] [Related]

  • 12. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
    Teunissen CE, Dijkstra CD, Jasperse B, Barkhof F, Vanderstichele H, Vanmechelen E, Polman CH, Bö L.
    Neuropathol Appl Neurobiol; 2006 Jun 15; 32(3):318-31. PubMed ID: 16640650
    [Abstract] [Full Text] [Related]

  • 13. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H, Stelmasiak Z.
    Neurol Neurochir Pol; 2002 Jun 15; 36(3):505-12. PubMed ID: 12185807
    [Abstract] [Full Text] [Related]

  • 14. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 15. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
    Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM.
    Ann Neurol; 2000 Mar 29; 47(3):391-5. PubMed ID: 10716264
    [Abstract] [Full Text] [Related]

  • 16. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N, Ben-Hur T, Karussis D, Milonas I.
    Clin Neurol Neurosurg; 2004 Jun 29; 106(3):211-7. PubMed ID: 15177770
    [Abstract] [Full Text] [Related]

  • 17. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec 29; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 18. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A.
    Neurologia; 2000 Dec 29; 15(7):288-302. PubMed ID: 11075577
    [Abstract] [Full Text] [Related]

  • 19. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 29; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 20. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.
    Arch Neurol; 2009 May 29; 66(5):601-9. PubMed ID: 19433660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.